JPS5665816A - Acetylsalicylate pharmaceutical for injection - Google Patents

Acetylsalicylate pharmaceutical for injection

Info

Publication number
JPS5665816A
JPS5665816A JP14163379A JP14163379A JPS5665816A JP S5665816 A JPS5665816 A JP S5665816A JP 14163379 A JP14163379 A JP 14163379A JP 14163379 A JP14163379 A JP 14163379A JP S5665816 A JPS5665816 A JP S5665816A
Authority
JP
Japan
Prior art keywords
pharmaceutical
acetylsalicylate
injection
stabilizing agent
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14163379A
Other languages
Japanese (ja)
Other versions
JPS6121529B2 (en
Inventor
Takashi Imagawa
Hirohisa Inahara
Masao Kagitani
Ryozo Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Priority to JP14163379A priority Critical patent/JPS5665816A/en
Publication of JPS5665816A publication Critical patent/JPS5665816A/en
Publication of JPS6121529B2 publication Critical patent/JPS6121529B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: The titled pharmaceutical, useful as an analgesic, antipyretic and an antirheumatic agent or for treating arthritis, neuralgia and myalgia, and comprising a specific amount of aminoacetic acid as a stabilizing agent in a powder pharmaceutical containing an acetylsalicylate for injection.
CONSTITUTION: A powder pharmaceutical containing an acetylsalicylate obtained by reacting acetylsalicylic acid with a basic amino acid, e.g. DL-form lysine, is incorporated with 1W15%(w/w) or more aminoacetic acid as a stabilizing agent selected for preventing the discoloration to give an acetylsalicylate pharmaceutical for injection. The addition of CaCl2 as a stabilizing agent for improving the storage stability provides a stabler pharmaceutical.
COPYRIGHT: (C)1981,JPO&Japio
JP14163379A 1979-11-01 1979-11-01 Acetylsalicylate pharmaceutical for injection Granted JPS5665816A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14163379A JPS5665816A (en) 1979-11-01 1979-11-01 Acetylsalicylate pharmaceutical for injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14163379A JPS5665816A (en) 1979-11-01 1979-11-01 Acetylsalicylate pharmaceutical for injection

Publications (2)

Publication Number Publication Date
JPS5665816A true JPS5665816A (en) 1981-06-03
JPS6121529B2 JPS6121529B2 (en) 1986-05-27

Family

ID=15296572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14163379A Granted JPS5665816A (en) 1979-11-01 1979-11-01 Acetylsalicylate pharmaceutical for injection

Country Status (1)

Country Link
JP (1) JPS5665816A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63307824A (en) * 1987-06-09 1988-12-15 Teisan Seiyaku Kk Stabilized powdery preparation for injection
WO1999018959A1 (en) * 1997-10-14 1999-04-22 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
WO2006128600A3 (en) * 2005-06-02 2007-04-26 Bayer Healthcare Ag Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
US7230014B1 (en) 1997-10-14 2007-06-12 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
JP2008114896A (en) * 2006-11-07 2008-05-22 Kyocera Mita Corp Auxiliary plate for taking out packed product

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01112835U (en) * 1988-01-26 1989-07-28

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63307824A (en) * 1987-06-09 1988-12-15 Teisan Seiyaku Kk Stabilized powdery preparation for injection
WO1999018959A1 (en) * 1997-10-14 1999-04-22 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
US7230014B1 (en) 1997-10-14 2007-06-12 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
WO2006128600A3 (en) * 2005-06-02 2007-04-26 Bayer Healthcare Ag Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
JP2008542316A (en) * 2005-06-02 2008-11-27 バイエル・ヘルスケア・アクチェンゲゼルシャフト Salts of o-acetylsalicylic acid with basic amino acids and stable active compound complexes of glycine
AU2006254429B2 (en) * 2005-06-02 2011-11-10 Bayer Intellectual Property Gmbh Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
US8063243B2 (en) 2005-06-02 2011-11-22 Bayer Pharma Aktiengesellschaft Stable active compound complex of salts of o-acetylsalicylic acid with basic amino acids and glycine
JP2008114896A (en) * 2006-11-07 2008-05-22 Kyocera Mita Corp Auxiliary plate for taking out packed product

Also Published As

Publication number Publication date
JPS6121529B2 (en) 1986-05-27

Similar Documents

Publication Publication Date Title
IL70286A (en) Omega-(1,3-disubstituted indol-2-yl-3,5-dihydroxy)alkanoic and-alkenoic acids and derivatives thereof,their production and pharmaceutical compositions containing them
JPS5610110A (en) Acetyl salicylate salt preparation for injection
JPS5665816A (en) Acetylsalicylate pharmaceutical for injection
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
JPS5655359A (en) Halogenated alpha-amino acid, and its preparation
ES8105691A1 (en) a salt of the d acid.
JPS5668672A (en) Novel 2-acetoxybenzamide derviative, its preparation, and pharmaceutical containing said derviative as effective component
JPS5334716A (en) Preparation of amide amine amphoteric surface active agent
JPS5726587A (en) Stabilization of ascorbic acid oxidase
JPS5441329A (en) Agent for promoting breeding of animal
JPS5422498A (en) Preparation of unsaturated polyester modified with epoxy resin
JPS52128288A (en) Glucose isomerase solution
JPS55127345A (en) Preparation of acetylsalicylic acid salt
JPS56145223A (en) Drug composition
JPS5527341A (en) Epoxy acrylate resin composition
EP0089198A3 (en) Nontoxic aspirin-containing composition
JPS5328116A (en) Preparation of glycine
JPS52154884A (en) Stabilization of cycloacetal resin
JPS5328119A (en) Preparation of pantetheine
JPS53134049A (en) Stabilization of synthetic resin
JPS5265242A (en) Preparation of d- and l-beta-(3,4-dihydroxyphenyl)-serine
JPS52128319A (en) Production of n-substituted amino-acid or its acid salt
JPS5226550A (en) Composite stabilizer compositions
JPS54154532A (en) Anti-inflammatory analgesic containing pyruvic acid amide
JPS55105650A (en) Preparation of amino-alkyl ester of amino acid